On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. Food and Drug Administration (FDA) regarding FDA’s recently published list of essential medicines, medical countermeasures (MCM), and their critical inputs. HSCA and our member companies are committed to ensuring continued patient access to critical medical products.
Click here to read the full comments.Lear More
Dear Chairman Alexander and Ranking Member Murray:
On behalf of the Healthcare Supply Chain Association (HSCA), we applaud your leadership to promote U.S. public health preparedness and response. Through commitment to advancing recommendations to help prepare for the next pandemic, we can best work to provide critical support in emergencies facing this nation. The unprecedented nature of the COVID-19 pandemic requires a whole-of-nation effort to ensure a coordinated and comprehensive response.
Click here to read the full comments.
Washington, DC (March 3, 2020) – Healthcare Supply Chain Association (HSCA) President and CEO Khatereh Calleja today released the following statement in conjunction with “An Emerging Disease Threat: How the U.S. Is Responding to COVID-19, the Novel Coronavirus,” a hearing before the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP):
“HSCA and its member healthcare group purchasing organizations (GPOs) applaud Senate HELP Committee Chair Lamar Alexander (R-TN) and Ranking Member Patty Murray (D-WA) for their focus on the United States’ efforts to prevent the spread of the coronavirus.
“Public health crises like the coronavirus place enormous stress on the entire healthcare system, including first responders, physicians, hospitals, other healthcare providers, and the patients they serve. HSCA and its member GPOs are working closely with Congress, the Administration, federal agencies, and all healthcare stakeholders throughout the healthcare delivery system to safeguard the supply chain and ensure hospitals and healthcare providers are equipped to treat and prevent the spread of this disease.
Click here to read the full statement.Lear More
Dear Senator Collins and Senator Smith,
The undersigned organizations are writing in support of S.2723 – The Mitigating Emergency Drug Shortages (MEDS) Act. Drug shortages have been on the rise for several years, with an estimated 210 drugs currently at risk or not readily available for U.S. hospitals, according to the national database maintained by the American Society of Health System Pharmacists (ASHP). The Food and Drug Administration (FDA) also states that drug shortages have grown more persistent since 2014 with many shortages lasting multiple years.
Click here to read the full letter.Lear More
HSCA Applauds Senators Collins and Smith for Bipartisan Legislation to Prevent and Mitigate Drug Shortages
Washington, DC (October 30, 2019) – Healthcare Supply Chain Association (HSCA) President and CEO Khatereh Calleja today released the following statement applauding Senator Susan Collins (R-ME) and Senator Tina Smith (D-MN) and announcing HSCA’s support for The Mitigating Emergency Drug Shortages (MEDS) Act:
“HSCA and its member group purchasing organizations (GPOs) applaud Senators Collins and Smith for their bipartisan leadership in addressing drug shortages, reducing healthcare costs, and improving patient outcomes for Americans across the country. HSCA strongly supports the MEDS Act, which builds upon the important steps Congress has taken to provide additional authority to the FDA to help mitigate drug shortages and develop market-based incentives to ensure a stable supply of medications critical for patient care.
Click here to read the full statement.Lear More
Washington, DC (April 30, 2019) – Healthcare Supply Chain Association (HSCA) President and CEO
Khatereh Calleja today released the following statement applauding the House Judiciary Committee
members for voting to advance the CREATES Act (H.R. 965):
“The Healthcare Supply Chain Association (HSCA) and its member group purchasing organizations
(GPOs) applaud Chairman Nadler, Ranking Member Collins, and the members of the House Judiciary
Committee for helping to increase competition in the generic drug marketplace by voting to advance the
CREATES Act. Americans rely on generic drugs to reduce costs and increase access to necessary
medication, and price spikes for commonly used drugs jeopardize patient access to care. HSCA supports
policy solutions like the CREATES Act that lower drug prices, encourage competition and innovation in
the marketplace, and end anti-competitive abuses utilized by some brand-name manufacturers. We
urge the House to quickly pass the CREATES Act to protect patient access to essential medications.”
Read the full statement here.Lear More